Abstract
BackgroundIdiopathic pulmonary fibrosis (IPF) is a rare disorder associated with increased mortality and morbidity. There are currently two drugs approved for IPF but their safety and efficacy profile in real-world...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have